Have reached agreement for Sputnik V trials in India, says Russia
New Delhi, Sept. 17 -- Russia's sovereign wealth fund said on Wednesday it has reached an agreement with pharmaceuticals major Dr Reddy's Laboratories for clinical trials and distribution of its experimental vaccine Sputnik V in India, a process that is yet to be cleared by the Drugs Controller General of India (DCGI)....
To read the full article or to get the complete feed from this publication, please
Contact Us.